A competing risk-based prognostic model for cancer-specific survival in non-metastatic head and neck adenoid cystic carcinoma

基于竞争风险的非转移性头颈部腺样囊性癌癌症特异性生存预后模型

阅读:1

Abstract

INTRODUCTION: Traditional Cox regression may yield biased estimates when competing events are present, limiting the accuracy of prognostic analyses in head and neck adenoid cystic carcinoma (HNACC). This study applied the Fine-Gray competing risks model to identify independent prognostic factors associated with HNACC-related mortality and develop a predictive nomogram using data from the Surveillance, Epidemiology, and End Results (SEER) database. METHODS: Patients diagnosed with HNACC between 2004 and 2015 were identified from the SEER database. Univariable analyses were performed using Gray's test and the cumulative incidence function, while multivariable analyses employed Cox regression and Fine-Gray proportional subdistribution hazards models. A nomogram was developed to predict 3-, 5-, and 10-year cancer-specific survival (CSS) and validated in an independent cohort. RESULTS: A total of 2,688 eligible patients were included. During follow-up, 1,046 deaths occurred, of which 673 were attributable to HNACC. The Fine-Gray model identified age, T-stage, N-stage, POCRT status, PORT status, and perineural invasion (PNI) as independent prognostic factors for CSS. These variables were incorporated into a nomogram that demonstrated excellent discrimination, with concordance indices of 0.818, 0.806, and 0.822 for 3-, 5-, and 10-year predictions in the training cohort, and 0.909, 0.931, and 0.965, respectively, in the validation cohort. CONCLUSIONS: The competing risks model identified key prognostic factors influencing CSS in HNACC. The derived nomogram provides individualized survival estimates, offering a practical tool to support clinical decision-making.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。